Not Prepared to Donate?

Here are 5 ways you can still help Aleteia:

  1. Pray for our team and the success of our mission
  2. Talk about Aleteia in your parish
  3. Share Aleteia content with friends and family
  4. Turn off your ad blockers when you visit
  5. Subscribe to our free newsletter and read us daily
Thank you!
Team Aleteia

Subscribe

Aleteia

Is a peanut allergy treatment on the horizon?

PEANUTS
AmberFOXphoto | Shutterstock
Share

Researchers can't cure a peanut allergy, but they may be able to treat it.

Peanut allergy is the most common type of food allergy, according to the Asthma and Allergy Foundation of America, and it’s often a life-threatening one. Children with peanut allergy often must be separated from their peers during meal times, among other careful measures to protect them from possible exposure.

But a new study published in the New England Journal of Medicine shows promising results for an individual’s reaction to peanuts to be diminished. In the study, two out of three children with a peanut allergy were able to safely consume two peanuts without any resulting symptoms.

“It does not make the allergy go away,” said lead author Dr. Brian Vickery. But the treatment could erase fears of accidental contamination for many with a life-threatening peanut allergy.

“I’m telling parents when I see them that my hope is that patients will have access by late next summer,” Vickery added.

If the treatment receives approval, many parents of children with peanut allergy could be resting much easier by late next year.

Newsletter
Get Aleteia delivered to your inbox. Subscribe here.
Aleteia offers you this space to comment on articles. This space should always reflect Aleteia values.
[See Comment Policy]
Readers like you contribute to Aleteia's Mission.

Since our inception in 2012, Aleteia’s readership has grown rapidly worldwide. Our team is committed to a mission of providing articles that enrich, inspire and inform a Catholic life. That's why we want our articles to be freely accessible to everyone, but we need your help to do that. Quality journalism has a cost (more than selling ads on Aleteia can cover). That's why readers like you make a major difference by donating as little as $3 a month.